11th Biosimilars Congregation 2017

 
11th Biosimilars Congregation 2017
“Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars”
06th December 2017, Kohinoor Continental Hotel, Mumbai, India

 Virtue insight is proud to present its 11th Biosimilars Congregation on 6th December 2017 at Kohinoor Continental Hotel, Mumbai – India. Discussions on  strategies for biosimilar product development Indian Pharmaceutical companies have started to look at biosimilars as a lucrative sector owing to the recent regulatory approvals and revenue generating opportunities. This event will discuss commercial strategies, insights on how regulatory & approval process work in region, opportunities for market expansion and highlights on R&D.

KEY SPEAKERS:
    •    MAYUR PARMAR, Drugs Inspector, FDA
    •    BINDU AJIT, Program Director, Biocon Academy
    •    MILIND NARVEKAR, Senior Director Generic Regulatory Affairs, Teva Pharmaceuticals
    •    LALIT LAKHWANI, Associate Director and Head of Clinical strategy, Dr. Reddy's Laboratories
    •    RAVISHANKAR KASTURI, Vice President - Development & Manufacturing, Reliance Life Sciences
    •    HANMANT BARKATE, Vice President & Head Medical affairs & Clinical Research, Wockhardt
    •    SAMIR KULKARNI, Independent Biosimilars Professional Expert
    •    SHUBHADEEP SINHA, Vice-President & Head (Global)- Clinical Development, Medical Affairs & Pharmacovigilance, Hetero Labs
    •    MANALI AGRAWAL, Head Regulatory Affairs, Bayer
    •    KIRAN KALAVADIA, Vice President, Cipla
    •    ANIL KUKREJA, Medical Director, Roche Pharmaceuticals
    •    ANITA KRISHNAN, Assistant Director, Head Bioanalytical Team, Lupin
    •    SONIKA SHAH. Regulatory Affairs Head. Amgen
    •    HEMANT DHAMNE, Senior Research Scientist, Intas Pharmaceuticals (Biopharma Division)
    •    VIJAY NAG THOTA, Head-Quality & Regulatory, SciGen BioPharma
    •    ALAP GANDHI, Head, Medical Affairs, Glaxo Smith Kline (GSK)
    •    ROSHAN PAWAR, Senior Medical Advisor, Oncology, Alkem Laboratories
    •    KARAN THAKKAR, Regional Clinical Site Lead, Pfizer
    •    ROSHAN PAWAR, Senior Medical Advisor, Oncology, Alkem Laboratories
    •    SRIVANI MUKKAMALA, Independent Consultant
    •    PRASHANT BODHE, Director, CliniSearch

CONFERENCE WEBPAGE:

http://www.virtueinsight.com/pharma/11th-Biosimilars-Congregation-2017/

CONFERENCE REGISTRATION PROCESSS:

You can e-mail your interest to fen@virtueinsight.co.in OR Tel- +91 44 64998743
    •    Early Bird Discounted Price (Until 24th October 2017) - (INR 6,000 + GST (18%) per delegate)
    •    Standard Price (25th October 2017 Onwards) –  (INR 7,000 + GST (18%) per delegate)
    •    Group Discounts – 3 or 4 Delegates - (INR 6,500 + GST (18%) per delegate)
    •    Group Discounts – 5 and above Delegates - (INR 6,000 + GST (18%) per delegate) 
    •    Spot Registration on the day of the Conference -(INR 8,000 + GST (18%) per delegate)
    •    Conference Sponsor & Exhibition Stall or a paid Speaker Slots are also available. You can simply email me your interests.
In order to register as delegate you can simply fill the last page of the attached file or e-mail me your invoice details in the below mentioned format; E-mail- fen@virtueinsight.co.in

    •    Name:
    •    GST Number (If Applicable):
    •    Company Name & Address:
    •    Job Position:
    •    Contact Number:

Join us to explore the current global climate for biosimilars, evaluate competition and benchmark with industry peers on how to navigate the changing regulations and landscape of the biosimilars market and effectively bring these programs to market.